Acetylcysteine/Doxofylline 1200/400 mg effervescent tablet

acetylcysteine; doxofylline · Neutec Ar-Ge San ve Tic A.Ş

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acetylcysteine/Doxofylline 1200/400 mg effervescent tablet, covering 2020-06-12 to 2020-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD. [Phase 4]

See pricing